Newsletter | February 29, 2024

02.29.24 -- Use-Related Risk Analysis For Combination Products

FEATURED EDITORIAL

Use-Related Risk Analysis For Combination Products

One of the most integral components in the development of drug-device combination products is the use-related risk analysis (URRA) and its applicability to the overall human factors engineering process. Deficiencies in the URRA are a leading cause of delays with FDA submissions.

INDUSTRY INSIGHTS

The Algorithm Is In: 5 Ways AI Is Transforming Medicine

AI is transforming the medical field, offering innovative solutions to complex problems. Explore the potential of AI in revolutionizing healthcare and leveraging data to improve patient experiences.

Medical Electronics Bring Care Closer To Patients

Digital healthcare methods are getting better at harnessing today’s advanced medical technologies. Here are a few areas where outcomes are improving as technology moves closer to patients.

Improving Medical Device Sustainability

Product design, production methods, and supply chain can be leveraged to positively impact sustainability through effective planning.

Computational Modeling Of Injection-Related Tissue Responses

Optimizing delivery along with the formulation is the key for successful clinical outcomes. Research is necessary to understand the relationship between body morphology, injection force, and needle length.

ARTICLES YOU MAY HAVE MISSED

5 Focus Areas For Medtech Business Success In 2024

Decoding The FDA's Draft Guidance On Computer Software Assurance For Medical Devices And Biopharma

EEG Technologies Grow Beyond Traditional Diagnostics

Human Factors Engineering Concepts For The Design Of Combination Products

Autoinjectors: Global Trends And Market Forecast

RESOURCES

RFID Tag Comparison Chart

Highly Flexible And Customizable On-Body Delivery System Platform

Connect With Med Device Online: